
Cycle Pharmaceuticals Launches PHYRAGO Tablets in US for Oncology
Cycle Pharmaceuticals announces the launch of PHYRAGO, its first oncology product in the US. PHYRAGO is launched in partnership with Handa Therapeutics, LLC, and will
Cycle Pharmaceuticals announces the launch of PHYRAGO, its first oncology product in the US. PHYRAGO is launched in partnership with Handa Therapeutics, LLC, and will
Cycle Pharmaceuticals has launched Cycle Vita PKU, an AI-powered app to help patients with PKU manage every aspect of their treatment plan. Health Technology Insights: